---
figid: PMC9663230__ECAM2022-6235771.003
pmcid: PMC9663230
image_filename: ECAM2022-6235771.003.jpg
figure_link: /pmc/articles/PMC9663230/figure/fig3/
number: Figure 3
figure_title: ''
caption: 'TRIM44 deficiency inhibits tumorigenesis in an EC xenograft model. ((a),
  (c)) The tumours were photographed. ((b), (d)) The tumour volume was calculated
  (n = 6). ((e)–(h)) The Ki-67, PCNA, and VEGF expression levels in tumour tissues
  were immunohistochemically evaluated. all data are presented as the mean ± SD. statistical
  significance: ∗P < 0.05 and ∗∗P < 0.01, compared with shNC; #P < 0.05 and ##P <
  0.01, compared with OE-NC.'
article_title: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the
  FRS2 Signalling Pathway.
citation: Yurong Song, et al. Evid Based Complement Alternat Med. 2022;2022:6235771.
year: '2022'

doi: 10.1155/2022/6235771
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
